Breast Cancer Clinical Trials

Showing 61-80 of 4,817 trials

RECRUITINGPhase 1

HER2 Vaccine for Locally Advanced Breast Cancer

NCT06949410

The goal of this study is to test an investigational vaccine to activate the immune system to fight breast cancer.

Breast CancerHER2-positive Breast Cancer

Pravin T.P Kaumaya36 participantsStarted Jun 2026

Indianapolis, Indiana, United States

RECRUITINGPhase 1

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

NCT06997029

The purpose of this study is to assess BMS-986500 as monotherapy in advanced solid tumors and as combination therapy in CDK4/6 inhibitor pre-treated advanced breast cancer.

Advanced Solid TumorAdvanced Breast CancerAdvanced Ovarian Cancer

Bristol-Myers Squibb234 participantsStarted Aug 2025

Birmingham, Alabama, United States • Fullerton, California, United States • Greenbrae, California, United States +18 more locations

HER2 Vaccine for Locally Advanced Breast Cancer

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Related Searches

Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment

Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease

Verification of Range Accuracy and Correlation With Clinical Toxicity Using Offline PET/CT for Hypofractionated Proton Radiotherapy in Breast Cancer

Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer

Predictive Clinical and Biological Parameters in Breast Cancer

A Study of the TheraBionic P1 Device in Breast Cancer

Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer

A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy

CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer

Prevention of CIPN Using Compressive Therapy